The structure of active serpin 1K from Manduca sexta

Structure

Volumn 7, Issue 1, 1999, Pages 103-109

  Li, Jinping ^a   Wang, Zhulun ^a   Canagarajah, Bertram ^a   Jiang, Haobo ^b   Kanost, Michael ^b   Goldsmith, Elizabeth J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

Active serpin structure; Crystal structure; Reactive center loop; Serpin 1K

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; OVALBUMIN; SERINE PROTEINASE INHIBITOR;

ARTICLE; CONFORMATIONAL TRANSITION; CRYSTALLOGRAPHY; ENZYME BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 0033555837     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(99)80013-6     Document Type: Article

References (43)

1. Travis, J. & Salvesen, G.S. (1983). Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52, 655-709.
2. Huber, R. & Carrell, R.W. (1989). Implications of the three-dimensional structure of α1-antitrypsin for structure and function of serpins. Biochemistry 28, 8951-8966.
3. Wright, H.T. (1996). The structural puzzle of how serpin serine proteinase inhibitors work. BioEssays 18, 453-464.
4. Wright, H.T., Qian, H.X. & Huber, R. (1990). Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. J. Mol. Biol. 213, 513-528.
5. Loebermann, H., Tokuoka, R., Deisenhofer, J. & Huber, R. (1984). Human α1-proteinase inhibitor. Crystal structure of two crystal modifications, molecular model and preliminary analysis of the implications for function. J. Mol. Biol. 177, 531-556.
6. Mottonen, J., et al., & Goldsmith, E.J. (1992). Structural basis of latency in plasminogen activator inhibitor-1. Nature 355, 270-273.
7. Bruch, M., Weiss, V. & Engel, J. (1988). Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites. J. Biol. Chem. 263, 16626-16630.
8. Wang, Z., Mottonen, J. & Goldsmith, E.J. (1996). Kinetically controlled folding of the serpin plasminogen activator inhibitor-1. Biochemistry 35, 16443-16448.
9. Whisstock, J., Skinner, R. & Lesk, A.M. (1998). An atlas of serpin conformations. Trends Biochem. Sci. 23, 63-67.
10. Wei, A., Rubin, H., Cooperman, B.S. & Christianson, D.W. (1994). Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory loop. Nat. Struct. Biol. 1, 251-258.
11. Stein, P.E., Leslie, A.G.W., Finch, J.T., Turnell, W.G., McLaughlin, P.J. & Carrell, R.W. (1990). Crystal structure of ovalbumin as a model for the reactive centre of serpins. Nature 347, 99-102.
12. Elliott, P.R., Lomas, D.A., Carrell, R.W. & Abrahams, J.P. (1996). Inhibitory conformation of the reactive loop of antitrypsin. Nat. Struct. Biol. 3, 676-681.
13. Ryu, S-E., Choi, H-J., Kwon, K-S., Lee, K.N. & Yu, M-H. (1996). The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: Crystal structure of an uncleaved α1-antitrypsin at 2.7 Å. Structure 4, 1181-1192.
14. Papamokos, E., et al., & Laskowski, M. (1982). Crystallographic refinement of Japanese quail ovomucoid, a Kazal-type inhibitor, and model building studies of complexes with serine proteases. J. Mol. Biol. 158, 515-537.
15. Madison, E.L., Goldsmith, E.J., Gerard, R., Gething, M.J. & Sambrook, J.F. (1989). Serpin-resistant mutants of human tissue-type plasminogen activator. Nature 339, 721-723.
16. Hopkins, P.C.R., Carrell, R.W. & Stone, S.R. (1993). Effects of mutations in the hinge region of serpins. Biochemistry 32, 7650-7657.
17. Schreuder, H.A., et al., & Hol, W.G.J. (1994). The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nat. Struct. Biol. 1, 48-54.
18. Carrell, R.W., Stein, P.E., Fermi, G. & Wardell, M.R. (1994). Biological implications of a 3 Å structure of dimeric antithrombin. Structure 2, 257-270.
19. Carrell, R.W., Evans, D.L. & Stein, P.E. (1991). Mobile reactive centre of serpins and the control of thrombosis. Nature 353, 576-578.
20. Björk, I., Nordling, K. & Olson, S.T. (1993). Immunologie evidence for insertion of the reactive-bond loop of antithrombin into the A β-sheet of the inhibitor during the trapping of target proteinases. Biochemistry 32, 6501-6505.
21. Mast, A.E., Enghild, J.J., Pizzo, S.V. & Salvesen, G. (1991). Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: Comparison of α1-antichymotrypsin, antithrombin III, α1-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry 30, 1723-1730.
22. Wilczynska, M., Fa, M., Karolin, J., Ohlsson, P.-I., Johansson, L.B.-A. & Ny, T. (1997). Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat. Struct. Biol. 4, 354- 357.
23. Stratikos, E. & Gettins, P.G.W. (1997). Major proteinase movement upon stable serpin-proteinase complex formation. Proc. Natl Acad. Sci. USA 94, 453-458.
24. Lawrence, D.A., et al., & Shore, J.D. (1995). Serpin-protease complexes are trapped as stable acyl-enzyme intermediates. J. Biol. Chem. 270, 25309-25312.
25. Jiang, H., Wang, Y. & Kanost, M.R. (1993). Mutually exclusive exon use and reactive center diversity in insect serpins. J. Biol. Chem. 269, 55-58.
26. Jiang, H. & Kanost, M.R. (1997). Characterization and functional analysis of 12 naturally occurring reactive site variants of serpin-1 from Manduca sexta. J. Biol. Chem. 272, 1082-1087.
27. Stein, P. & Chothia, C. (1991). Serpin tertiary structure transformation. J. Mol. Biol. 221, 615-621.
28. Olson, S.T., et al., & Bjork, I. (1995). Role of the catalytic serine in the interactions of serine proteinases with protein inhibitors of the serpin family: Contribution of a covalent interaction to the binding energy of serpin-proteinase complexes. J. Biol. Chem. 270, 30007-30017.
29. Plotnick, M.I., Mayne, L., Schechter, N.M. & Rubin, H. (1996). Distortion of the active site of chymotrypsin complexed with a serpin. Biochemistry 35, 7586-7590.
30. Jiang, H., Mulnix, A.B. & Kanost, M.R. (1995). Expression and characteriztion of recombinant Manduca sexta-1B and site-directed mutants that change its inhibitory selectivity. Insect Biochem. Mol. Biol. 24, 1093-1100.
31. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989). Molecular Cloning. (2nd Edn). Cold Spring Harbor Laboratory Press, New York.
32. Jancarik, J. & Kim, S.-H. (1991). Sparse matrix sampling: A screening method for crystallization of proteins. J. Appl. Cryst. 24, 409-411.
33. Otwinowski, Z. (1993). Oscillation data reduction program. In Data Collection and Processing. (Sawyer, L., Issacs, N. & Bailey, S.W. eds), pp. 56-82, Daresbury Laboratory, Daresbury, UK.
34. Navaza, J. (1994). AMoRe: An automated package for molecular replacement. Acta Cryst. A 50, 157-163.
35. Read, R.J. (1986). Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Cryst. A 42, 140-149,
36. Collaborative Computational Project, Number (1994). The CCP4 suite: Programs for protein crystallography. Acta Cryst D 50, 760- 763.
37. Jones, T.A. & Kjeldgaard, M. (1991 ). O Version 5.4. Uppsala University, Sweden.
38. Brünger, A.T. (1993). X-PLOR Manual (Version 3.1): A System for X- Ray Crystallography and NMR. Yale University Press, New Haven, CT.
39. Laskowski, R.A., MacArthur, M.W., Moss, D.S. & Thornton, J.M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26, 283-291.
40. Kraulis, P.J. (1991). MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24, 946-950.
41. Evans, S.V. (1993). SETOR: Hardware lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11, 134-138.
42. Esnoust, B.M. (1997). An extensively modified version of MOLSCRIPT that includes greatly enhanced coloring capabilities. J. Mol. Graph. 15, 133-138.
43. Nicholls, A., Sharp, K.A. & Honig, B. (1991). Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.